hypoglycemia and glp-1 Science Behind GLP 1 GIP Glucagon Receptor Agonists for Obesity Research | News & Announcements Diagnosis and Management of Post-Bariatric

Ro Launches Wegovy Pill Through Integration with Novo Nordisk Ro to play critical role in ensuring patients nationwide get access to first and only oral GLP-1 weight loss medication at the lowest available cash price January 5, 2026 -- Ro, the leading direct-to-patient healthcare company, announced today that it is working with Novo Nordisk on the nationwide launch of the new Wegovy pill

GLP-1 receptor agonist medications are prescription drugs do not start, stop, or change your dosage without guidance from a licensed healthcare provider

These drugs are produced by Novo Nordisk and Eli Lilly, which both recently announced agreements with the Trump administration to lower prices

Our team is dedicated to helping you reach your goals and will make sure you have the support you need throughout your weight loss journey

Lotte Bjerre Knudsen (02:16): Yeah, thank you for that question

American Pharmacists Association